Dicerna Pharmaceuticals
$26.989876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$26.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.33 (-4.70%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell DRNA and other stocks, options, and ETFs commission-free!
About DRNA
Dicerna Pharmaceuticals, Inc. Common Stock, also called Dicerna Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA. The listed name for DRNA is Dicerna Pharmaceuticals, Inc. Common Stock.
CEO
Douglas M. Fambrough, III, PhD
Employees
187
Headquarters
Lexington, Massachusetts
Founded
2007
Market Cap
2.04B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
811.62K
High Today
$28.25
Low Today
$25.56
Open Price
$27.72
Volume
1.73M
52 Week High
$29.45
52 Week Low
$11.75
DRNA News
Analyst Ratings
100%
of 10 ratings
Buy
100%
Hold
0%
Sell
0%
DRNA Earnings
-$0.58
-$0.20
$0.17
$0.55
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.03 per share
Actual
-$0.49 per share